Intrahepatic cholangiocarcinoma: Relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics

Abdominal Imaging

Volumn 38, Issue 4, 2013, Pages 785-792

  Nanashima, Atsushi ^a   Abo, Takafumi ^a   Murakami, Goushi ^a   Matsumoto, Aya ^a   Tou, Kazuo ^a   Takeshita, Hiroaki ^a   Kunizaki, Masaki ^a   Hidaka, Shigekazu ^a   Sakamoto, Ichiro ^a   Hayashi, Hideyuki ^a   Fukuda, Toru ^b   Kudo, Takashi ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Intrahepatic cholangiocarcinoma; Multidetector computed tomography; Prognosis hepatectomy; Tumor enhancement

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CAPILLARY DENSITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEPATITIS; HUMAN; IMAGE ENHANCEMENT; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84882268591     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-012-9974-3     Document Type: Article

References (45)

1. Su CH, Tsay SH, Wu CC, et al. (1996) Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223:384-394
2. Isa T, Kusano T, Shimoji H, et al. (2001) Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 181:507-511
3. Kawarada Y, Yamagiwa K, Das BC (2002) Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183:679-685
4. Kozaka K, Sasaki M, Fujii T, et al. (2007) A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. Histopathology 51:390-400
5. Roskams T (2006) Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 25:3818-3822
6. Sempoux C, Jibara G, Ward SC, et al. (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31:49-60
7. de Martel C, Plummer M, Franceschi S (2010) Cholangiocarcinoma: descriptive epidemiology and risk factors. Gastroenterol Clin Biol 34:173-180
8. Khan SA, Davidson BR, Goldin R, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51:1-9
9. Sano T, Kamiya J, Nagino M, et al. (1999) Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:101-107
10. Hirohashi K, Uenishi T, Kubo S, et al. (2002) Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49:326-329
11. Suzuki S, Sakaguchi T, Yokoi Y, et al. (2002) Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 26:687-693
12. Ohtsuka M, Ito H, Kimura F, et al. (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89:1525-1531
13. Thelen A, Scholz A, Weichert W, et al. (2010) Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepaticcholangiocarcinoma. Am J Gastroenterol 105:1123-1132
14. Miura F, Okazumi S, Takayama W, et al. (2004) Hemodynamics of intrahepatic cholangiocarcinoma: evaluation with single-level dynamic CT during hepatic arteriography. Abdom Imaging 29:467-471
15. Kim JE, Kim SH, Lee SJ, Rhim H (2011) Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol 196:W758-W765
16. Nanashima A, Sumida Y, Abo T, et al. (2008) Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol 98:535-539
17. Nanashima A, Shibata K, Nakayama T, et al. (2009) Relationship between microvessel count and postoperative survival in patients with intrahepaticcholangiocarcinoma. Ann Surg Oncol 16:2123-2129
18. Nanashima A, Yoshinaga M, Yamaguchi H, et al. (2003) An immunohistochemical study of tumor vascularity and proliferation activity in cholangiocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection. Acta Med Nagasaki 48:23-27
19. Khan SA, Thomas HC, Davidson BR, et al. (2005) Cholangiocarcinoma. Lancet 366:1303-1314
20. Lazaridis KN, Gores GJ (2005) Cholangiocarcinoma. Gastroenterology 128:1655-1667
21. Fukukura Y, Hamanoue M, Fujiyoshi F, et al. (2000) Cholangiolocellular carcinoma of the liver: CT and MR findings. J Comput Assist Tomogr 24:809-812
22. Jung AY, Lee JM, Choi SH, et al. (2006) CT features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. J Comput Assist Tomogr 30:173-181
23. Song SJ, Lee JM, Kim YJ, et al. (2007) Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 26:86-93
24. Nakanuma Y, Xu J, Harada K, et al. (2011) Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases. Pathol Int 61:298-305
25. Xu J, Igarashi S, Sasaki M, et al. (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 32:1156-1164
26. Xu J, Sasaki M, Harada K, et al. (2011) Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis. Histopathology 59:1090-1099
27. Jung EM, Ross CJ, Rennert J, et al. (2010) Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: first results. Clin Hemorheol Microcirc 46:89-99
28. Nanashima A, Yamaguchi H, Shibasaki S, et al. (2006) Relationship between CT volumetry and functional liver volume using technetium-99 m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study. Dig Dis Sci 51:1190-1195
29. Liver Cancer Study group of Japan (2003). In: Makuuchi M, (ed). The general rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara Co., pp 6-28.
30. Park HS, Lee JM, Choi JY, et al. (2008) Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 190:396-405
31. Chamberlain RS, Blumgart LH (1999) Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol 7:55-66
32. Valls C, Gumà A, Puig I, et al. (2000) Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25:490-496
33. Sano T, Kamiya J, Nagino M, et al. (1999) Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6:101-107
34. Sanada Y, Yoshida K, Itoh H (2007) Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: assessment of malignant potential with claudin-10 immunohistochemistry. Oncol Rep 17:1177-1182
35. Kim NR, Lee JM, Kim SH, et al. (2008) Enhancement characteristics of cholangiocarcinomas on mutiphasic helical CT: emphasis on morphologic subtypes. Clin Imaging 32:114-120
36. Kim SJ, Lee JM, Han JK, et al. (2007) Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 189:1428-1434
37. Hai S, Kubo S, Yamamoto S, et al. (2005) Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 22:432-439
38. Polizos A, Kelekis N, Sinani C, et al. (2003) Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: case report and review of the literature. Eur J Gastroenterol Hepatol 15:331-334
39. Perumal V, Wang J, Thuluvath P, et al. (2006) Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 37:1211-1216
40. Alison MR (2005) Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev 1:253-260
41. Acalovschi M (2004) Cholangiocarcinoma: risk factors, diagnosis and management. Rom J Intern Med 42:41-58
42. Yamamoto M, Ariizumi S, Otsubo T, et al. (2004) Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma. J Surg Oncol 87:80-83
43. Asayama Y, Yoshimitsu K, Irie H, et al. (2006) Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238:150-155
44. Shirabe K, Shimada M, Tsujita E, et al. (2004) Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis. Am J Surg 187:538-542
45. Leelawat K, Leelawat S, Ratanachu-Ek T, et al. (2006) Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients. World J Gastroenterol 12:4195-4198